Hypothermic total liquid ventilation after experimental aspiration-associated acute respiratory distress syndrome

Abstract

BackgroundUltrafast cooling by total liquid ventilation (TLV) provides potent cardio- and neuroprotection after experimental cardiac arrest. However, this was evaluated in animals with no initial lung injury, whereas out-of-hospital cardiac arrest is frequently associated with early-onset pneumonia, which may lead to acute respiratory distress syndrome (ARDS). Here, our objective was to determine whether hypothermic TLV could be safe or even beneficial in an aspiration-associated ARDS animal model.MethodsARDS was induced in anesthetized rabbits through a two-hits model including the intra-tracheal administration of a pH = 1 solution mimicking gastric content and subsequent gaseous non-protective ventilation during 90 min (tidal volume [Vt] = 10 ml/kg with positive end-expiration pressure [PEEP] = 0 cmH2O). After this initial period, animals either received lung protective gas ventilation (LPV; Vt = 8 ml/kg and PEEP = 5 cmH2O) under normothermic conditions, or hypothermic TLV (TLV; Vt = 8 ml/kg and end-expiratory volume = 15 ml/kg). Both strategies were applied for 120 min with a continuous monitoring of respiratory and cardiovascular parameters. Animals were then euthanized for pulmonary histological analyses.ResultsEight rabbits were included in each group. Before randomization, all animals elicited ARDS with arterial oxygen partial pressure over inhaled oxygen fraction ratios (PaO2/FiO2) below 100 mmHg, as well as decreased lung compliance. After randomization, body temperature rapidly decreased in TLV versus LPV group (32.6 ± 0.6 vs. 38.2 ± 0.4 °C after 15 min). Static lung compliance and gas exchanges were not significantly different in the TLV versus LPV group (PaO2/FiO2 = 62 ± 4 vs. 52 ± 8 mmHg at the end of the procedure, respectively). Mean arterial pressure and arterial bicarbonates levels were significantly higher in TLV versus LPV. Histological analysis also showed significantly lower inflammation in TLV versus LPV group (median histological score = 3 vs. 4.5/5, respectively; p = 0.03).ConclusionHypothermic TLV can be safely induced in rabbits during aspiration-associated ARDS. It modified neither gas exchanges nor respiratory mechanics but reduced lung inflammation and hemodynamic failure in comparison with LPV. Since hypothermic TLV was previously shown to provide neuro- and cardio protective effects after cardiac arrest, these findings suggest a possible use of TLV in the settings of cardiac arrest-associated ARDS.

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome

“…Eighty-two NRDS patients who were admitted to our hospital from August 2017 to June 2019, 82 were selected. The inclusive criteria included meeting the relevant diagnostic criteria of NRDS in Practical Neonatology, 9 having not receiving glucocorticoid treatment before delivery, and being transferred to intensive care unit within 12 hours after birth. Exclusive criteria included preterm infants who were suspected of pulmonary dysplasia, had congenital metabolic diseases, chromosomal abnormalities, congenital cardiopulmonary malformations, and severe anemia, had severe intravascular hemolysis shown by prenatal ultrasound, and had severe dyspnea at birth.…”

Penehyclidine hydrochloride alleviates lipopolysaccharide‑induced acute respiratory distress syndrome in cells via regulating autophagy‑related pathway

“…Bluish skin coloration, shortness of breath and rapid breathing are also prominent symptoms of ARDS ( 4 ). The high mortality of ARDS has received increasing attention, with several studies indicating that ARDS may be closely associated with conditions such as pancreatitis ( 5 , 6 ), sepsis ( 7 ), aspiration ( 8 ), pneumonia ( 9 ) and trauma ( 10 ). ARDS pathogenesis comprises diffuse cell damage, including diffuse cell injury, pulmonary microballoon barrier formation, surfactant dysfunction, immune system activation and coagulation regulation dysfunction ( 11 , 12 ).…”

Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-κB Pathway

“…Although the mechanisms underlying the progression of steatosis towards more aggressive stage of NAFLD still remain largely unknown, the ‘two-hit' hypothesis has been widely accepted. Aggregation of lipids in the cytoplasm of liver cells (first hit) brings about a series of cytotoxic events (second hit), resulting in liver inflammation [4]. Currently, no approved medication for NAFLD treatment is available, other than lifestyle advice on diet and exercise.…”